Stéphanie Leclercq ☢️ 🤓
8.2K posts

Stéphanie Leclercq ☢️ 🤓
@10davidstreet
Don’t count the days, make the days count! 🇮🇲
Isle of Man, United Kingdom Katılım Kasım 2010
1.1K Takip Edilen463 Takipçiler
Stéphanie Leclercq ☢️ 🤓 retweetledi


@Garnstudio Im trying to ask a question about Polar Days on website but can't post it. Is there an email I can send it to? Desperate to continue knitting but Im stuck!

English

@3FMradio Does it mean they fetch me faster if I have an emergency?
English
Stéphanie Leclercq ☢️ 🤓 retweetledi

@Escapation
Check this out absolutely amazing, Super Geisha did it in one shot, Nuclear Nerd took one tweak. Both of these collections will live again in the OtherSide
@OthersideMeta @_PPMan_ @CryptoGarga @BoredApeYC @BoredApeGazette


English
Stéphanie Leclercq ☢️ 🤓 retweetledi

This is wild, turns out it’s not huge Megacorps or Governments that are gonna run the world it’s Cecil and Venus @cecilweishaupt @venusventura0
Matthew Berman@MatthewBerman
Moltbots/Clawdbots now have their own social network (@moltbook) and it's wild. This is the first time I'm a little scared... You need to watch this.
English

Following a fantastic JPM Conference for the Breyer Capital team and portfolio, I'm excited to share our 2026 Healthcare & Life Sciences Predictions next week—ten inflection points where we see technological maturity meeting market readiness. We'll also be featuring predictions from top portfolio companies on where they see their industries heading.
Going into the long weekend, here are three predictions we feel most strongly about:
1. The Great HealthTech Consolidation: 2026 will be a banner year for private market healthcare tech M&A. Distribution became the defining moat in 2025, with portfolio company leaders like OpenEvidence and Abridge deploying at scale. Over the next 12 months, boardrooms will grapple with the question: consolidate to achieve distribution dominance and defend economics, or get acquired before commoditization erodes market position and valuation.
2. Clinical AI Enters Both the Exam Room and the Boardroom: The greatest impact of AI in medicine will be measurement—removing longstanding observational constraints by quantifying new signals from audio, video, wearables, and molecular data. Companies like Iterative Health, Cleerly, and ArteraAI are already converting continuous biological signals into actionable clinical insights. This year, we will strengthen business models that reward better measurement across providers, payers, and life sciences, with CMS's ACCESS model launching July 2026 providing a critical tailwind.
3. The In Vivo Renaissance Accelerates: Cell and gene therapy is shifting from ex vivo approaches costing $1M+ per patient to in vivo delivery that edits cells directly inside the body, transforming both economics and access. In vivo delivery vehicles now achieve tissue-specific targeting with acceptable safety profiles, and can be manufactured at scale like traditional biologics. In 2026, more in vivo leaders will emerge, possessing differentiated delivery technology and manufacturing approaches achieving pharma-scale economics.
Full report drops next week!
English
Stéphanie Leclercq ☢️ 🤓 retweetledi

GM Fam! ☀️🦍Big News today!
@DillasApeChain soon in @OthersideMeta 👀
Huge shoutout to my 3D team and my guy @RidazLp2 for bringing the Dillas character to life — metaverse ready.
🧠 New year. New drops.
👀 Next phase loading.
🔥 Dillas never left.
@ApeChainHUB
English

@BoredApeYC Maybe in the Christmas stocking @ulysseus I’ve been good!!
English

Only a limited number of posters remain, each hand-signed by our lead illustrator, Chomps.
Order by December 16th at 10pm PT to receive your items in time for Christmas.
store.boredapeyachtclub.com


English

@CamillaTominey you’re such a breathe of fresh air on the airwaves!!! Never stop uncovering the truth!!!
English

@Gedpower We sat at your table and played some backgammon - good shout thank you!
English

@10davidstreet Derby House? Next door to stunning unused Baillie Scott building.
English

@Gedpower @AlibabaTeapot Sounding more and more appealing!
English

@spectator Bless them - discounting cash flows is probably too difficult
English

The Treasury says the real cost over 99 years is £3.4 billion. To make the right calculation, one must discount future nominal payments by the inflation rate.
✍️ Charles Moore
spectator.co.uk/article/the-tr…
English

@Pausrr @WelcomeApes @imcaptainsplash @BoredApeYC That’s a great mutant! I’m +1 of three mutant holder @ulysseus two of them are twins!!!
English

Gm @WelcomeApes I would like to introduce my long-time homie @imcaptainsplash to the Club! Came to ApeFest as my +1… left as a Mutant holder 💥
Welcome to the swamp bro you deserve it!
🧠🦍
Best club on the internet! @BoredApeYC

English






